Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tilray Medical-branded cannabis flower products are pharmaceutical-grade medical cannabis medicines developed by Tilray Medical, a division of Tilray Brands, Inc. These products consist of dried cannabis flower derived from the *Cannabis sativa* plant and are available in various strains, including THC-dominant, CBD-dominant, and balanced THC/CBD varieties. The primary active ingredients are the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which act as agonists at the endocannabinoid receptors, specifically the CB1 and CB2 receptors. Manufactured in EU-GMP-certified facilities, these products are prescribed for conditions such as chronic pain, nausea, anxiety, and epilepsy in markets where medical cannabis is legally authorized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tilray Medical-branded cannabis flower products.